Health Care & Life Sciences » Biotechnology | Jiangsu Sihuan Bioengineering Co. Ltd.

Jiangsu Sihuan Bioengineering Co. Ltd. A | Ownership

Companies that own Jiangsu Sihuan Bioengineering Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
1,119,200
0.11%
0
0%
07/31/2018
E Fund Management Co., Ltd.
624,002
0.06%
-153,000
0%
12/31/2017
GF Fund Management Co., Ltd.
623,900
0.06%
58,300
0.01%
12/31/2017
Lion Fund Management Co., Ltd.
175,900
0.02%
175,900
0.01%
12/31/2017
China Southern Asset Management Co., Ltd.
88,700
0.01%
-18,300
0%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
64,800
0.01%
55,900
0.01%
12/31/2017
Da Cheng Fund Management Co., Ltd.
50,700
0.01%
-12,800
0%
12/31/2017
Rongtong Fund Management Co., Ltd.
21,200
0%
-3,900
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
16,300
0%
-2,900
0%
12/31/2017
Truvalue Asset Management Co. Ltd.
0
0%
-176,970
0%
12/31/2017

About Jiangsu Sihuan Bioengineering Co.

View Profile
Address
No. 10 Dingshan Road
Wuxi Jiangsu 214434
China
Employees -
Website -
Updated 07/08/2019
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It specializes in biopharmaceuticals, chemical pharmaceutical, and health products. The company was founded on May 18, 1992 and is headquartered in Wuxi, China.